Jan 22 (Reuters) - IRadimed Corp IRMD.O :
* IRADIMED CORPORATION EXPECTS MINOR IMPACT TO 2019 REVENUE
AFTER
TEMPORARILY SUSPENDING SHIPMENTS OF MRI COMPATIBLE PATIENT VITAL
SIGNS MONITORING SYSTEMS IN EUROPEAN MARKETS
* IRADIMED CORP SAYS EXPECTS NEGATIVE IMPACT TO FULL-YEAR
2019
REVENUE OF APPROXIMATELY TWO PERCENT
* IRADIMED CORP SAYS TEMPORARILY SUSPENDED SALES OF 3880 MRI
COMPATIBLE PATIENT VITAL SIGNS MONITORING SYSTEMS IN EUROPEAN
COMMISSION MARKETS
* IRADIMED-AFTER CONSIDERING SUSPENDING SHIPMENTS OF MRI
COMPATIBLE PATIENT VITAL SIGNS MONITORING SYSTEMS IMPACT, STILL
EXPECT MID 20 PERCENT REVENUE GROWTH IN 2019
Source text for Eikon: ID:nGNX74V3Bn
Further company coverage: IRMD.O
((Reuters.Briefs@thomsonreuters.com;))